Pancreatic Cysts.
Gonda TA, Cahen DL, Farrell JJ.
N Engl J Med. 2024 Sep 5;391(9):832-843. doi: 10.1056/NEJMra2309041.
Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE, Gutmann DH.
Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9.
Comparison of Society Guidelines for the Management and Surveillance of Pancreatic Cysts: A Review.
Aziz H, Acher AW, Krishna SG, Cloyd JM, Pawlik TM.
JAMA Surg. 2022 Aug 1;157(8):723-730. doi: 10.1001/jamasurg.2022.2232.
[Neurofibromatosis].
Matthies C, Rampeltshammer E, Breun M.
Fortschr Neurol Psychiatr. 2023 May;91(5):213-232. doi: 10.1055/a-2000-3713. Epub 2023 May 16.
Control group design, contamination and drop-out in exercise oncology trials: a systematic review.
Steins Bisschop CN, Courneya KS, Velthuis MJ, Monninkhof EM, Jones LW, Friedenreich C, van der Wall E, Peeters PH, May AM.
PLoS One. 2015 Mar 27;10(3):e0120996. doi: 10.1371/journal.pone.0120996. eCollection 2015.
Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.
Jackson M, Ahmari N, Wu J, Rizvi TA, Fugate E, Kim MO, Dombi E, Arnhof H, Boehmelt G, Düchs MJ, Long CJ, Maier U, Trapani F, Hofmann MH, Ratner N.
J Pharmacol Exp Ther. 2023 May;385(2):106-116. doi: 10.1124/jpet.122.001431. Epub 2023 Feb 27.
Current controversies in pancreatic cystic neoplasms.
Walsh RM.
Am J Surg. 2017 Mar;213(3):443-447. doi: 10.1016/j.amjsurg.2017.01.009. Epub 2017 Jan 11.
Benign breast disease.
Hamed H, Fentiman IS.
Int J Clin Pract. 2001 Sep;55(7):461-4.
Association between control group therapy and magnitude of clinical benefit of cancer drugs.
Molto C, Tibau A, Bujosa A, Tapia JC, Mittal A, Tamimi F, Amir E.
Sci Rep. 2022 Dec 9;12(1):21342. doi: 10.1038/s41598-022-25983-9.
Endoscopic neurosurgery.
Auer LM, Holzer P, Ascher PW, Heppner F.
Acta Neurochir (Wien). 1988;90(1-2):1-14. doi: 10.1007/BF01541260.
